Gender Bias AI

Testing and Correcting Gender Bias in Healthcare AI

David Alvaro, Ph.D.

Pharma's Almanac

Ovarian Cancer

Oncolytic Viruses at a Turning Point: Advancing Olvi-Vec for Advanced Ovarian Cancer

David Alvaro, Ph.D.; Jason Litten, M.D.

Pharma's Almanac

Pain and Pregnancy

When Signals Fade: What the Acetaminophen–Autism Debate Teaches About Evidence, Design, and Causality

David Alvaro, Ph.D.

Pharma's Almanac

Ovarian Cancer

Ovarian Cancer at an Inflection Point: Quantifying the Burden, Closing Gaps, and Accelerating Next-Generation Therapies

David Alvaro, Ph.D.

Pharma's Almanac

Mental Health

The Mental Health Gender Gap: Why Women Bear the Burden

Maggie Palmiero

Pharma's Almanac

Autoimmune Diseases

Decoding the Gender Imbalance: How Sex, Hormones, and Immunity Collide in Autoimmune Disease

Chia Chia Sun; David Alvaro, Ph.D.

Fab Biopharma

Women's Health

10 Women’s Health Biotechs to Watch: Beyond the Biology, Toward Equity

Pharma's Almanac

Autoimmune Diseases

Pain, Misdiagnosis, and Autoimmune Disease: Untangling Complexity and Bias

Chia Chia Sun; David Alvaro, Ph.D.

Fab Biopharma

Women in Science

What progress has the industry made in advancing women in leadership, R&D, and clinical roles?

Pharma's Almanac

Gender

The Business Case for Gender-Inclusive Pharma: Why Equity Drives Innovation, Performance, and Profit

David Alvaro, Ph.D.

Pharma's Almanac

Inclusive Trials

Inclusive Trials Are Better Trials: Why Women’s Health Can’t Be a Footnote Anymore

Emilee Kudla

Pharma's Almanac

Pregnancy Research

The Other Data Gap: Reimagining Clinical Research to Include Pregnant and Lactating Women

David Alvaro, Ph.D.

Pharma's Almanac

Gender Equity

Achieving Gender Equity Without Saying “Gender” or “Women”

Heather Harmon

Pharma's Almanac

Wearables

Closing the Gender Gap in Digital Health and Wearable Technologies

David Alvaro, Ph.D.

Pharma's Almanac

Women in Leadership

Breaking the Biopharma Glass Ceiling: Why Female Leadership Still Lags

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Sex Differences

Half the Data, Half the Science: The Cost of Ignoring Sex Differences in Preclinical Research

David Alvaro, Ph.D.

Pharma's Almanac

WHI

A Reversal Isn’t a Rescue: Women’s Health Still Needs Defending

David Alvaro, Ph.D.

Pharma's Almanac